CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 160 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $14,412,224 | +208.3% | 523,700 | +280.1% | 0.00% | – |
Q2 2023 | $4,675,011 | -73.6% | 137,784 | -72.1% | 0.00% | -100.0% |
Q1 2023 | $17,739,760 | +95.4% | 493,045 | +142.1% | 0.00% | +100.0% |
Q4 2022 | $9,078,417 | +58.7% | 203,689 | +0.2% | 0.00% | 0.0% |
Q3 2022 | $5,719,000 | -56.0% | 203,383 | -57.8% | 0.00% | -50.0% |
Q2 2022 | $12,995,000 | -62.6% | 482,027 | -52.7% | 0.00% | -60.0% |
Q1 2022 | $34,708,000 | +193.6% | 1,019,024 | +233.1% | 0.01% | +400.0% |
Q4 2021 | $11,821,000 | +23.3% | 305,933 | +72.3% | 0.00% | 0.0% |
Q3 2021 | $9,584,000 | +132.7% | 177,536 | +44.2% | 0.00% | 0.0% |
Q2 2021 | $4,118,000 | +809.1% | 123,159 | +459.7% | 0.00% | – |
Q1 2021 | $453,000 | +32.1% | 22,005 | +12.6% | 0.00% | – |
Q4 2020 | $343,000 | +45.3% | 19,546 | +23.1% | 0.00% | – |
Q3 2020 | $236,000 | -21.6% | 15,879 | -31.4% | 0.00% | – |
Q2 2020 | $301,000 | +812.1% | 23,142 | +18.7% | 0.00% | – |
Q1 2020 | $33,000 | -31.2% | 19,503 | -7.9% | 0.00% | – |
Q4 2019 | $48,000 | +140.0% | 21,170 | +124.1% | 0.00% | – |
Q3 2019 | $20,000 | -33.3% | 9,446 | -15.1% | 0.00% | – |
Q2 2019 | $30,000 | +172.7% | 11,132 | +372.1% | 0.00% | – |
Q1 2019 | $11,000 | – | 2,358 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kynam Capital Management, LP | 2,600,000 | $88,218,000 | 12.13% |
Octagon Capital Advisors LP | 759,898 | $25,783,339 | 3.59% |
TSP Capital Management Group, LLC | 251,895 | $8,546,800 | 3.08% |
ACUTA CAPITAL PARTNERS, LLC | 122,343 | $4,151,098 | 2.81% |
5AM Venture Management, LLC | 310,270 | $10,527,461 | 2.62% |
COMMODORE CAPITAL LP | 631,665 | $21,432,393 | 2.41% |
RTW INVESTMENTS, LP | 3,463,201 | $117,506,410 | 2.24% |
Eversept Partners, LP | 785,740 | $26,660,158 | 2.23% |
Redmile Group, LLC | 1,696,004 | $57,545,416 | 2.21% |
Affinity Asset Advisors, LLC | 87,031 | $2,952,962 | 1.03% |